down arrow

GemPharmatech Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100005964
CNY
15.26
-0.57 (-3.6%)

Dec 16

SHG

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
GemPharmatech Co., Ltd.
Why is GemPharmatech Co., Ltd. ?
1
Poor long term growth as Net Sales has grown by an annual rate of 13.13% and Operating profit at 11.03% over the last 5 years
2
The company has declared Negative results for the last 5 consecutive quarters
  • NET PROFIT(HY) At CNY 40.43 MM has Grown at -40.41%
  • DEBT-EQUITY RATIO (HY) Highest at -41.48 %
  • INTEREST(Q) At CNY 1.08 MM has Grown at 13.08%
3
With ROE of 4.80%, it has a fair valuation with a 1.25 Price to Book Value
  • Over the past year, while the stock has generated a return of 8.07%, its profits have fallen by -32.6%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to GemPharmatech Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is GemPharmatech Co., Ltd. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
GemPharmatech Co., Ltd.
8.07%
0.67
47.19%
China Shanghai Composite
14.03%
0.97
14.44%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
13.13%
EBIT Growth (5y)
11.03%
EBIT to Interest (avg)
41.84
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.44
Sales to Capital Employed (avg)
0.29
Tax Ratio
9.02%
Dividend Payout Ratio
51.99%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.99%
ROE (avg)
6.83%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
26
Industry P/E
Price to Book Value
1.25
EV to EBIT
18.81
EV to EBITDA
9.21
EV to Capital Employed
1.48
EV to Sales
2.36
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
7.88%
ROE (Latest)
4.80%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Mildly Bullish
Moving Averages
Mildly Bullish (Daily)
KST
Mildly Bearish
Bullish
Dow Theory
Mildly Bearish
Mildly Bearish
OBV
No Trend
Mildly Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
OPERATING CASH FLOW(Y)

Highest at CNY 133.37 MM

INVENTORY TURNOVER RATIO(HY)

Highest at 4.86%

-20What is not working for the Company
NET PROFIT(HY)

At CNY 40.43 MM has Grown at -40.41%

DEBT-EQUITY RATIO (HY)

Highest at -41.48 %

INTEREST(Q)

At CNY 1.08 MM has Grown at 13.08%

INTEREST COVERAGE RATIO(Q)

Lowest at 2,208.95

OPERATING PROFIT(Q)

Lowest at CNY 23.8 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 14.01 %

Here's what is working for GemPharmatech Co., Ltd.
Inventory Turnover Ratio
Highest at 4.86% and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Operating Cash Flow
Highest at CNY 133.37 MM
in the last three years
MOJO Watch
The company has generated higher cash revenues from business operations

Operating Cash Flows (CNY MM)

Here's what is not working for GemPharmatech Co., Ltd.
Net Profit
At CNY 40.43 MM has Grown at -40.41%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is very negative

Net Profit (CNY MM)

Interest
At CNY 1.08 MM has Grown at 13.08%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (CNY MM)

Interest Coverage Ratio
Lowest at 2,208.95
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Debt-Equity Ratio
Highest at -41.48 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Operating Profit
Lowest at CNY 23.8 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (CNY MM)

Operating Profit Margin
Lowest at 14.01 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."